Study shows skin cancer link to NSAID use

The population-based case-control study showed that those who had ever used NSAIDs (defined as >2 prescriptions) had a 15% decreased risk of SCC and a 13% decreased risk of developing melanoma.

The authors said the effect increased with greater duration and intensity of use, which may reflect a cumulative, dose-dependent effect.

Use was not associated with a reduced risk of basal cell carcinoma overall, but long-term and high-intensity use resulted in a reduced risk of developing it on areas of the body